Annexin II heterotetramer (AIIt) is a Ca
2؉-and phospholipid-binding protein that consists of two copies of a p36 and p11 subunit. AIIt regulates the production and autoproteolysis of plasmin at the cell surface. In addition to its role as a key cellular protease, plasmin also plays a role in angiogenesis as the precursor for antiangiogenic proteins. Recently we demonstrated that the primary antiangiogenic plasmin fragment, called A 61 (Lys
-Lys
468) was released from cultured cells. In the present study we report for the first time that AIIt possesses an intrinsic plasmin reductase activity. AIIt stimulated the reduction of the plasmin Cys
462-Cys 541 bond in a time-and concentration-dependent manner, which resulted in the release of A 61 from plasmin. Mutagenesis of p36 C334S and either p11 C61S or p11 C82S inactivated the plasmin reductase activity of the isolated subunits, suggesting that specific cysteinyl residues participated in the plasmin reductase activity of each subunit. Furthermore, we demonstrated that the loss of AIIt from the cell surface of HT1080 cells transduced with a retroviral vector encoding p11 antisense dramatically reduced the cellular production of A 61 from plasminogen. This is the first demonstration that AIIt regulates the cellular production of the antiangiogenic plasminogen fragment, A 61 .Angiostatin was originally identified in the urine of mice bearing Lewis lung carcinoma as a 38-kDa proteolytically derived fragment of plasminogen which encompassed the first four kringle domains (Lys 78 -Ala 440 ). Angiostatin was shown to be a potent antiangiogenic protein that inhibited the growth of human and murine carcinomas and also induced dormancy in their metastases. Angiostatin was also characterized as a specific antiangiogenic protein that blocked microvascular endothelial cell proliferation but not the proliferation of nonendothelial cells (1).It is now apparent that angiostatin is a member of a family of antiangiogenic plasminogen fragments (AAPFs).1 Physiologically relevant AAPFs include a 38-kDa AAPF isolated from the conditioned media of tumor-infiltrating macrophages (2) and AAPFs of 48, 42, and 50 kDa present in macrophage-conditioned media (3). Other AAPFs include a 50-kDa AAPF isolated from the conditioned media of human prostate carcinoma PC-3 cells (4, 5) and AAPFs of 66, 60, and 57 kDa detected in the conditioned media of HT1080 and Chinese hamster ovary cells (6). Because the carboxyl terminus of most of these AAPFs was not determined, the exact primary sequence of most of the AAPFs is not known. Two distinct pathways for the formation of AAPFs have been identified. First, certain proteinases can directly cleave plasminogen into AAPFs. These proteinases include metalloelastase, gelatinase B (matrix metalloproteinase-9), stromelysin-1 (matrix metalloproteinase-3), matrilysin (matrix metalloproteinase-7), cathepsin D, and prostate-specific antigen (7-11). The source of these proteinases may be tumor-infiltrating macrophages (2) or the cancer cells themselves. For example...